miffybaccarat| Fu 'an Pharmaceutical: The subsidiary received the approval notice for the supplementary application for granisetron hydrochloride tablets

News summary

[Fu 'an Pharmaceuticalmiffybaccarat: The subsidiary received the approval notice for the supplementary application for granisetron hydrochloride tablets] Securities Times e Company NewsmiffybaccaratFu 'an Pharmaceutical (300194) announced on the evening of May 22 that its wholly-owned subsidiary Tianheng Pharmaceutical recently received granisetron hydrochloride tablets issued by the State Food and Drug Administrationmiffybaccarat.miffybaccarat..

Newsletter text

[Fu 'an Pharmaceutical: The subsidiary received the approval notice for the supplementary application for granisetron hydrochloride tablets] Securities Times e Company News, Fu' an Pharmaceutical (300194) announced on the evening of May 22 that its wholly-owned subsidiary Tianheng Pharmaceutical has recently received the approval notice for the supplementary application for granisetron hydrochloride tablets issued by the State Food and Drug Administration. Granisetron hydrochloride tablets are mainly used for nausea and vomiting caused by radiotherapy and cytotoxic chemotherapy. Up to now, Tianheng Pharmaceutical's product is the first in China to pass the consistency evaluation or be deemed to have passed the consistency evaluation.

Tags:

Prev: sevenseasbingo| The identity of the "Prophet" was announced and held 700 shares!
Next: megamillionsjackpotamount| The track has entered its golden five years! Lin Yuan personally attended the meeting for research!